Name | Number of supported studies | Average coverage | |
---|---|---|---|
platelet | 11 studies | 84% ± 19% | |
megakaryocyte | 6 studies | 80% ± 19% |
Insufficient scRNA-seq data for expression of PPBP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 541.65 | 558 / 578 | 31% | 3.03 | 362 / 1155 |
spleen | 100% | 1411.02 | 240 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 2821.73 | 755 / 929 | 0% | 0 | 0 / 0 |
intestine | 1% | 0.46 | 9 / 966 | 51% | 122.23 | 267 / 527 |
thymus | 25% | 20.50 | 163 / 653 | 25% | 1.47 | 149 / 605 |
liver | 41% | 33.88 | 92 / 226 | 5% | 0.30 | 20 / 406 |
stomach | 2% | 2.19 | 7 / 359 | 42% | 46.26 | 119 / 286 |
kidney | 17% | 12.18 | 15 / 89 | 25% | 1.06 | 221 / 901 |
esophagus | 3% | 2.24 | 37 / 1445 | 34% | 4.73 | 63 / 183 |
pancreas | 0% | 0 | 0 / 328 | 31% | 19.86 | 55 / 178 |
bladder | 5% | 279.19 | 1 / 21 | 26% | 32.27 | 130 / 504 |
brain | 2% | 1.31 | 57 / 2642 | 26% | 1.23 | 180 / 705 |
adipose | 23% | 20.23 | 278 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 1.34 | 9 / 258 | 19% | 0.79 | 43 / 230 |
uterus | 2% | 1.57 | 4 / 170 | 20% | 2.26 | 91 / 459 |
breast | 17% | 11.85 | 76 / 459 | 3% | 0.13 | 32 / 1118 |
skin | 6% | 3.72 | 110 / 1809 | 8% | 0.51 | 40 / 472 |
heart | 14% | 12.16 | 117 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.55 | 6 / 45 |
ovary | 1% | 0.43 | 2 / 180 | 11% | 0.27 | 46 / 430 |
blood vessel | 8% | 7.93 | 106 / 1335 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.80 | 13 / 803 | 0% | 0 | 0 / 0 |
prostate | 0% | 0.14 | 1 / 245 | 1% | 0.04 | 5 / 502 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_1904659 | Biological process | glucose transmembrane transport |
GO_0042742 | Biological process | defense response to bacterium |
GO_0005615 | Cellular component | extracellular space |
GO_1904724 | Cellular component | tertiary granule lumen |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0045236 | Molecular function | CXCR chemokine receptor binding |
GO_0005355 | Molecular function | glucose transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
GO_0008083 | Molecular function | growth factor activity |
Gene name | PPBP |
Protein name | Platelet basic protein (PBP) (C-X-C motif chemokine 7) (Leukocyte-derived growth factor) (LDGF) (Macrophage-derived growth factor) (MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III (CTAP-III) (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81) (CTAP-III(1-81)); Beta-thromboglobulin (Beta-TG); Neutrophil-activating peptide 2(74) (NAP-2(74)); Neutrophil-activating peptide 2(73) (NAP-2(73)); Neutrophil-activating peptide 2 (NAP-2); TC-1; Neutrophil-activating peptide 2(1-66) (NAP-2(1-66)); Neutrophil-activating peptide 2(1-63) (NAP-2(1-63))] |
Synonyms | SCYB7 THBGB1 CTAP3 CXCL7 TGB1 |
Description | FUNCTION: LA-PF4 stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by human synovial cells. NAP-2 is a ligand for CXCR1 and CXCR2, and NAP-2, NAP-2(73), NAP-2(74), NAP-2(1-66), and most potent NAP-2(1-63) are chemoattractants and activators for neutrophils. TC-1 and TC-2 are antibacterial proteins, in vitro released from activated platelet alpha-granules. CTAP-III(1-81) is more potent than CTAP-III desensitize chemokine-induced neutrophil activation. . |
Accessions | ENST00000296028.4 P02775 |